Open AccessAdjuvant radiotherapy in central hepatocellular carcinoma after narrow-margin hepatectomy: A 10-year real-world evidence
Author(s) -
Weiqi Rong,
Wei Yu,
Liming Wang,
Fan Wu,
Kai Zhang,
Bin Chen,
Changxing Miao,
Liguo Liu,
Senyou An,
Changcheng Tao,
Weihu Wang,
Jianxiong Wu
Publication year - 2020
Publication title -
chinese journal of cancer research/chinese journal of cancer research
Language(s) - English
Resource type - Journals
eISSN - 1993-0631
pISSN - 1000-9604
DOI - 10.21147/j.issn.1000-9604.2020.05.09
Subject(s) - medicine , adjuvant , hepatocellular carcinoma , log rank test , radiation therapy , adjuvant radiotherapy , resection margin , hepatectomy , adverse effect , adjuvant therapy , hazard ratio , gastroenterology , proportional hazards model , surgery , chemotherapy , resection , confidence interval
A prospective randomized control study investigated the feasibility and efficacy of adjuvant radiotherapy on patients with central hepatocellular carcinoma (HCC) after narrow-margin hepatectomy (<1 cm). This study presents an updated 10-year real-world evidence to further characterize the role of adjuvant radiotherapy.